CYTOSTATIC ANTICANCER DRUG DEVELOPMENT - PRECLINICAL STUDIES AND EARLY CLINICAL-TRIALS (FRANKFURT MAIN, NOVEMBER 1989)

被引：0
|
作者：
BERDEL, WE [1 ]
FIEBIG, HH [1 ]
机构：
[1] UNIV FREIBURG,DEPT INTERNAL MED,DIV HEMATOL & ONCOL,W-7800 FREIBURG,GERMANY
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1990年 / 116卷 / 02期
关键词：
D O I：
10.1007/BF01612682
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：224 / 227
页数：4
相关论文
共 50 条
  • [31] Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review
    Jorda, Anselm
    Zeitlinger, Markus
    CLINICAL PHARMACOKINETICS, 2020, 59 (09) : 1071 - 1084
  • [32] Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review
    Pecho, Theresa
    Zeitlinger, Markus
    CLINICAL PHARMACOKINETICS, 2024, 63 (01) : 13 - 26
  • [33] Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review
    Anselm Jorda
    Markus Zeitlinger
    Clinical Pharmacokinetics, 2020, 59 : 1071 - 1084
  • [34] Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions
    Scicchitano, Francesca
    Constanti, Andrew
    Citraro, Rita
    De Sarro, Giovambattista
    Russo, Emilio
    CURRENT DRUG TARGETS, 2015, 16 (07) : 747 - 756
  • [35] Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes
    Saijo, N
    Nishio, K
    Ohta, S
    Arioka, H
    Funayama, Y
    Fukuoka, K
    Kurokawa, H
    Nomoto, T
    Ishida, T
    Yamamoto, N
    Tamura, T
    Shinkai, T
    Eguchi, K
    Ohe, Y
    Kunito, H
    Ohtsu, T
    Sasaki, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 : S11 - S15
  • [36] STATISTICAL CONCEPTS IN THE PLANNING AND EVALUATION OF DRUG SAFETY FROM CLINICAL-TRIALS IN DRUG DEVELOPMENT - ISSUES OF INTERNATIONAL HARMONIZATION
    ONEILL, RT
    STATISTICS IN MEDICINE, 1995, 14 (9-10) : 1117 - 1127
  • [37] OSTEOARTHRITIS ANTIRHEUMATIC DRUG TRIALS .3. SETTING THE DELTA FOR CLINICAL-TRIALS - RESULTS OF A CONSENSUS DEVELOPMENT (DELPHI) EXERCISE
    BELLAMY, N
    CARETTE, S
    FORD, PM
    KEAN, WF
    LERICHE, NGH
    LUSSIER, A
    WELLS, GA
    CAMPBELL, J
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (03) : 451 - 457
  • [38] Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
    Johnson, JI
    Decker, S
    Zaharevitz, D
    Rubinstein, LV
    Venditti, J
    Schepartz, S
    Kalyandrug, S
    Christian, M
    Arbuck, S
    Hollingshead, M
    Sausville, EA
    BRITISH JOURNAL OF CANCER, 2001, 84 (10) : 1424 - 1431
  • [39] Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
    J I Johnson
    S Decker
    D Zaharevitz
    L V Rubinstein
    J M Venditti
    S Schepartz
    S Kalyandrug
    M Christian
    S Arbuck
    M Hollingshead
    E A Sausville
    British Journal of Cancer, 2001, 84 : 1424 - 1431
  • [40] Unintended drug exposure during pregnancy in clinical trials - a survey in early drug development
    Erb-Zohar, Katharina
    Sourgens, Hildegard
    Breithaupt-Groegler, Kerstin
    Klipping, Christine
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (01) : 26 - 30
12345